Want to see NBP full AI Analyst Report?
NovaBridge Biosciences (NBP) Income Statement
NovaBridge Biosciences Income Statement
Last quarter (Q2 2026), NovaBridge Biosciences's total revenue was $0.00. In Q2, NovaBridge Biosciences's net income was $-18.87M. See NovaBridge Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 4.49M | $ -10.70M | $ 88.03M | |
| $ 0.00 | $ 0.00 | $ 4.49M | $ -10.70M | $ 41.59M | |
| $ 13.48M | $ 375.36M | $ 515.65M | $ 355.38M | $ 2.11B | |
| Depreciation and Amortization | $ 856.00K | $ 7.11M | $ 7.68M | $ 9.48M | $ 31.63M |
| $ -12.62M | $ -368.25M | $ -339.94M | $ -356.60M | $ -2.04B | |
| $ -13.48M | $ -375.36M | $ -511.16M | $ -366.08M | $ -2.07B | |
| $ 847.61K | $ 12.63M | $ -954.53M | $ -607.09M | $ -260.73M | |
| $ -12.63M | $ -362.73M | $ -1.47B | $ -973.17M | $ -2.33B | |
| $ -6.61M | $ -162.26M | $ -1.47B | $ -967.52M | $ -2.33B | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.16 | $ -4.46 | $ -17.62 | $ -30.38 | $ -30.70 |
| Diluted EPS | $ -0.16 | $ -4.46 | $ -17.62 | $ -30.38 | $ -30.68 |
| Weighted Average Shares Outstanding | 41.64M | 81.19M | 83.19M | 82.52M | 75.93M |
| Weighted Average Shares Outstanding (Diluted) | 41.64M | 81.19M | 83.23M | 82.52M | 75.96M |
Currency in CNY
